Biotech | March 11, 2026
Cirena licenses breakthrough RNA synthesis technology from CU Boulder
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Subscribe To Our Newsletter & Stay Updated
